Bowen D - Search Results

1

Guidelines for the diagnosis and management of adult myelodysplastic syndromes.

Killick SB, Carter C, Culligan D, Dalley C, Das-Gupta E, Drummond M, Enright H, Jones GL, Kell J, Mills J, Mufti G, Parker J, Raj K, Sternberg A, Vyas P, Bowen D; British Committee for Standards in Haematology. Killick SB, et al. Among authors: bowen d. Br J Haematol. 2014 Feb;164(4):503-25. doi: 10.1111/bjh.12694. Epub 2013 Dec 23. Br J Haematol. 2014. PMID: 24372298 Free article. No abstract available.

2

Circulating erythropoietin in patients with myelodysplastic syndromes.

Jacobs A, Janowska-Wieczorek A, Caro J, Bowen DT, Lewis T. Jacobs A, et al. Among authors: bowen dt. Br J Haematol. 1989 Sep;73(1):36-9. doi: 10.1111/j.1365-2141.1989.tb00215.x. Br J Haematol. 1989. PMID: 2803975

3

Refractory anaemia with preleukaemic polyclonal haemopoiesis and the emergence of monoclonal erythropoiesis on disease progression.

Culligan DJ, Bowen DT, May A, White D, Padua RA, Burnett AK. Culligan DJ, et al. Among authors: bowen dt. Br J Haematol. 1995 Mar;89(3):675-7. doi: 10.1111/j.1365-2141.1995.tb08389.x. Br J Haematol. 1995. PMID: 7734379

4

Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.

Bowen DT, Culligan D, Beguin Y, Kendall R, Willis N. Bowen DT, et al. Leukemia. 1994 Jan;8(1):151-5. Leukemia. 1994. PMID: 8289479

5

Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients.

Bowen DT, Denzlinger C, Brugger W, Culligan D, Gelly K, Adlakha S, Groves M, Hepburn M, Kanz L. Bowen DT, et al. Br J Haematol. 1998 Dec;103(3):785-7. doi: 10.1046/j.1365-2141.1998.01045.x. Br J Haematol. 1998. PMID: 9858231 Free article. Clinical Trial.

6

Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.

Tauro S, Hepburn MD, Bowen DT, Pippard MJ. Tauro S, et al. Among authors: bowen dt. Haematologica. 2001 Oct;86(10):1038-45. Haematologica. 2001. PMID: 11602409

7

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes.

Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, Parker J; UK MDS Guidelines Group. Bowen D, et al. Br J Haematol. 2003 Jan;120(2):187-200. doi: 10.1046/j.1365-2141.2003.03907.x. Br J Haematol. 2003. PMID: 12542475 Free article. No abstract available.

8

A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia.

Killick SB, Mufti G, Cavenagh JD, Mijovic A, Peacock JL, Gordon-Smith EC, Bowen DT, Marsh JC. Killick SB, et al. Among authors: bowen dt. Br J Haematol. 2003 Feb;120(4):679-84. doi: 10.1046/j.1365-2141.2003.04136.x. Br J Haematol. 2003. PMID: 12588356 Free article. Clinical Trial.

9

Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia.

Johan MF, Bowen DT, Frew ME, Goodeve AC, Wilson GA, Peake IR, Reilly JT. Johan MF, et al. Among authors: bowen dt. Br J Haematol. 2004 Mar;124(6):843-4. doi: 10.1111/j.1365-2141.2004.04862.x. Br J Haematol. 2004. PMID: 15009076 Free article. No abstract available.

10

Thalidomide therapy for low-risk Myelodysplasia.

Bowen D, MacIlwaine L, Cavanagh J, Killick S, Culligan D, Thomson E, Mufti G. Bowen D, et al. Leuk Res. 2005 Feb;29(2):235-6. doi: 10.1016/j.leukres.2004.05.017. Leuk Res. 2005. PMID: 15607375 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,506 results

Search Page

Filters